Do you want to publish a course? Click here

Role of Surgery in theManagement of Cancer of Body and Tail of Pancreas

دور المعالجة الجراحية في تدبير سرطان جسم و ذيل البنكرياس

444   0   11   0 ( 0 )
 Publication date 2009
  fields Medicine
and research's language is العربية
 Created by Shamra Editor




Ask ChatGPT about the research

Evaluation of the management of cancer in the body and tail of the pancreas with determining the role of surgery in the management of these tumors. The study was performed retrospectively. It included all patients who were admitted in Al Assad University Hospital in Damascus between 2003 and 2008 in the diagnosis of cancer in the body or tail of the pancreas. The data were collected by reviewing the hospital files, radiological reports, and surgical reports of these patients.

References used
Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 1996; 223:506-12
Falconi M, Mantovani W, Bettini R, Talamini G, Bassi C, Cascinu S, et al. Carcinoma of pancreatic body and tail: are there improvements in diagnosis and treatment modalities over the past decade? Dig Liver Dis 2003; 35:421-7
Dalton, RR; Sarr, MG; van Heerden, JA; Colby, TV. Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery. 1992May;111(5):489–494
rate research

Read More

A retrospective study included 25 cases with inflammatory breast cancer. The patients were admitted to AL-Assad University Hospital, Lattakia, Syria (average age 55, and range 49-61 years old). The most common clinical signs and symptoms were: erythe ma 100%, edema 100%, enlarged axillary nodes 100%, Nipple flattened/inverted 96%, warm Breast 92%, Ridges/thickening of breast 84%, Peau d’orange 88%, painful/tender Breast 88%, and Mass 80%. Mammography findings were: an increase in skin thickness 100%, an increased tissue density in the involved breast 100%, and an asymmetric widening of the sub-cutaneous lymphatic vessels 33.33%. 80% of cases were diagnosed as stage IV. All patients received primary neoadjuvant chemotherapy for three cycles. After that a modified radical breast mastectomy and axillary lymph nodes dissection were performed for all patients. The wound edges were closed primarily after dissecting the skin in 76%, for 4 patients 16% a split-thickness skin grafts were performed, and for 2 patients 8% a Latissimus dorsi pedicled myocutaneous flap was performed.
This study was carried out in AL-ASSAD University Hospital during the years 2005- 2015, and included 56 patients who have been treated of gastric cancer. Male: Female ratio was 1:1.85, the peak incidence was in the 6th and 7th decades 60%, the heig hest incidence was in lower third of stomach in 65% of cases. Adenocarcinoma (FUNGATING FORM) was the most common pathological macroscopic form 45%,. The most common operation was subtotal gastrectomy 71.05% with Omega, Brown anastomosis 52.63%, interiorly of the colon, in the two third of cases.D1 dissection was performed in 92.1% of cases, compared with D2 dissection which was performed in 6.9% of cases.Spleenectoy was performed in 15.7% of cases, and the cholecystectomy was performed in 2.5% of cases.Stage ɪɪ and stage ɪɪɪ constitute 90% of cases.
recurrence is a major problem which affects 40% of Breast cancer patients . Bcl2 is an antiapoptotic protein which is implicated in many cases of cancer development and cancer resistance to therapy. Aim of study : investigate the role of Bcl2 in recurrence in Breast cancer patients
The standard treatment for superficial TCC of the bladder is the endoscopic resection of all visible tumours. Transurethral resection (TUR) may fail to control superficial disease, especially in patients with higher tumour stages (T1), in addition to the high recurrence rate. To evaluate the role of a second transurethral resection (early re-resection) in reducing the high recurrence rate of T1 bladder tumours .
Background: people with cancer experience great changes in their life as a result of disease, treatment and disease prognosis which affect their quality of life .with the goal of investigating breast cancer patient's quality of life during chemother apy in Tishreen hospital in Latakia.. Methods: 60 patients were invited to complete the European organization of research and treatment quality of life questionnaire version 3 and breast cancer quality of life module during their early stage of chemotherapy. Results : the results show that the (73.3%) were under the age of fifty and half of them reported total health status score under (50) which reflects low quality of life in addition to impaired psychological ,social, cognitive and role functioning. Also more than 67% of patient suffered from chemotherapy- related side effects as nausea and vomiting, dyspnea, loss of appetite, insomnia, and fatigue. In addition to variance in quality of life scores according to age, marital status, occupation and level of education without changing of it by educational level. In addition to that the majority of patient had impaired sexual function and upset of hair loss and arm symptoms but with positive and optimistic future. perspective. No significant differences in quality of life scores were found between urban and rural patients. Conclusion. Health care provider should assess routinely cancer patient quality of life during treatment to ascertain of providing appropriate care with supportive services for all patients

suggested questions

comments
Fetching comments Fetching comments
Sign in to be able to follow your search criteria
mircosoft-partner

هل ترغب بارسال اشعارات عن اخر التحديثات في شمرا-اكاديميا